News & Press Releases
- 2014, January
- 2013, December
- 2013, November
- 2013, September
- 2013, August
- 2013, July
- 2013, April
- 2012, May
- 2011, August
- 2011, July
- 2011, April
- 2011, February
- 2008, June
- 2007, June
- 2006, December
- 2006, November
- 2006, September
- 2006, August
- 2006, June
- Archived Press Releases
Miraculins executes Term Sheet to Appoint Cachet Pharmaceutical as Exclusive Distributor of the Scout DSŪ Diabetes Test in China.
Miraculins and Cachet Pharmaceutical agree to 30-Day Extension on Letter of Intent to Continue Negotiation of Licensing Rights for SCOUT DSŪ Diabetes Test in China.
Miraculins files Pre-submission Documentation with the USFDA for its Scout DSŪ Diabetes Testing Technology.
Miraculins announces 2014 Plans for its Scout DSŪ Non-Invasive Diabetes Screening Technology.
Miraculins signs Letter of Intent with Beijing-Based Cachet Pharmaceutical to Negotiate Licensing Rights for SCOUT DSŪ Diabetes Test in China.
Miraculins SCOUT DSŪ Non-Invasive Diabetes Screening Test to be piloted by Major Canadian Supermarket Chain
Miraculins highlights New Peer-Reviewed Publications on SCOUT DSŪ.
Miraculins reappoints Pear Healthcare Solutions to Distribute Scout DSŪ to Canadian Retail Pharmacy/Grocery Market.
Miraculins completes acquisition of VeraLight’s Scout DS Technology.
Miraculins executes Final Agreement for Acquisition of VeraLights Scout DSŪ Non-Invasive Diabetes Screening Technology.
Miraculins executes Term Sheet to acquire VeraLight’s Scout DS Technology.
VeraLight announces Mexico approval of the SCOUT DSŪ for non-invasive diabetes screening and exclusive distribution agreement with TekSalud.
VeraLight announces distribution agreement with Pear Healthcare Solutions for SCOUT DS.
VeraLight announces CE mark approval of the SCOUT DS for non-invasive diabetes screening.
VeraLight announces Health Canada licence approval of the SCOUT DS for non-invasive diabetes screening.
VeraLight closes Series C financing.
VeraLight previews SCOUT DS® instrument at 2007 ADA Scientific Sessions in Chicago.
VeraLight presents clinical study results at the 19th World Diabetes Congress of the International Diabetes Federation.
VeraLight presents poster on superior detection of impaired glucose tolerance at 2006 Diabetes Technology Meeting.
VeraLight presents clinical study results at Scientific Assembly of American Academy of Family Physicians.
VeraLight closes Series B financing.
Study shows new non-invasive device screens diabetes better than fasting plasma glucose test.